Towards targeting anticancer drugs: ruthenium(ii)-arene complexes with biologically active naphthoquinone-derived ligand systems

Dalton Trans. 2016 Aug 16;45(33):13091-103. doi: 10.1039/c6dt01110a.

Abstract

Anticancer active metal complexes with biologically active ligands have the potential to interact with more than one biological target, which could help to overcome acquired and/or intrinsic resistance of tumors to small molecule drugs. In this paper we present the preparation of 2-hydroxy-[1,4]-naphthoquinone-derived ligands and their coordination to a Ru(II)(η(6)-p-cymene)Cl moiety. The synthesis of oxime derivatives resulted in the surprising formation of nitroso-naphthalene complexes, as confirmed by X-ray diffraction analysis. The compounds were shown to be stable in aqueous solution but reacted with glutathione and ascorbic acid rather than undergoing reduction. One-electron reduction with pulse radiolysis revealed different behavior for the naphthoquinone and nitroso-naphthalene complexes, which was also observed in in vitro anticancer assays.

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Ascorbic Acid / chemistry
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Coordination Complexes / chemistry*
  • Coordination Complexes / pharmacology
  • Cymenes
  • Drug Resistance, Neoplasm
  • Glutathione / chemistry
  • Humans
  • Monoterpenes / chemistry*
  • Monoterpenes / pharmacology
  • Naphthoquinones / chemistry*
  • Naphthoquinones / pharmacology
  • Ruthenium / chemistry*
  • Ruthenium / pharmacology

Substances

  • Antineoplastic Agents
  • Coordination Complexes
  • Cymenes
  • Monoterpenes
  • Naphthoquinones
  • 4-cymene
  • Ruthenium
  • Glutathione
  • Ascorbic Acid